Immuneering Appoints Andrew Gengos as Chief Financial Officer
Immuneering Corporation appoints Andrew Gengos, former CFO of Terns Pharmaceuticals, as new Chief Financial Officer. Gengos brings over 25 years of leadership in biotech finance and business development. He will guide financial strategy as the company advances its lead oncology drug, atebimetinib, currently in Phase 3 trials targeting pancreatic ca…